Drug profile · INN
darbepoetin alfa
ARANESP
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
darbepoetin alfa (ARANESP) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN darbepoetin alfa
Brand ARANESP
Route SUBCUTANEOUS
Formulation VIAL
ATC code B03XA02
Frequently asked questions
What is darbepoetin alfa?
darbepoetin alfa (ARANESP) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for darbepoetin alfa?
ARANESP is a marketed brand name for darbepoetin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of darbepoetin alfa?
darbepoetin alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.